Longer Patents for Lower Imitation Barriers: The 1984 Drug Act

dc.contributor.author	John Vernon
dc.date.accessioned	2010-03-09T15:23:58Z
dc.date.available	2010-03-09T15:23:58Z
dc.date.issued	1986
dc.identifier.uri	https://hdl.handle.net/10161/1848
dc.description.abstract	In this paper we analyze its likely impacts on competition in the pharmaceutical industry, the incentives for innovation, and general consumer welfare.
dc.format.extent	553678 bytes
dc.format.mimetype	application/pdf
dc.language.iso	en_US
dc.publisher	American Economic Review
dc.subject	1984 Drug Act
dc.subject	Imitation barriers
dc.subject	Impact of ANDAs
dc.subject	Longer patents
dc.title	Longer Patents for Lower Imitation Barriers: The 1984 Drug Act
dc.type	Journal article